TrialBritish journal of cancer1997

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.

J F Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.